Tay S S, Clark A T, Deighton J, King Y, Ewan P W
Department of Medicine, Cambridge University, Cambridge, UK.
Clin Exp Allergy. 2007 Oct;37(10):1512-8. doi: 10.1111/j.1365-2222.2007.02802.x.
The clinical significance of food-specific IgG subclasses in food allergy and tolerance remains unclear. Specific IgG titres are often reported in non-standardized units, which do not allow comparisons between studies or allergens.
To quantify, in absolute units, ovalbumin (OVA)- and peanut-specific IgG levels in children with peanut or egg allergy (active or resolved) and in non-allergic controls. Methods Children aged 1-15 years were recruited. Peanut allergy was diagnosed by convincing history and a 95% predictive level of specific IgE; egg allergy or resolution was confirmed by oral challenge. Serum IgG, IgG1 and IgG4 levels (microg/mL) to OVA and peanut extract were quantified by ELISA.
OVA- and peanut-specific IgG was detected in all subjects. In non-allergic controls (n=18), OVA-specific IgG levels were significantly higher than peanut-specific IgG (median microg/mL IgG=15.9 vs. 2.2, IgG1=1.3 vs. 0.6, IgG4=7.9 vs. 0.7; P<0.01). There were no differences in OVA-specific IgG, IgG1 and IgG4 between egg-allergic (n=40), egg-resolved (n=22) and control (n=18) subjects. In contrast, peanut-specific IgG (median microg/mL IgG=17.0, IgG1=3.3, IgG4=5.2) were significantly higher in peanut-allergic subjects (n=59) compared with controls and with non-peanut-sensitized but egg-allergic subjects (n=26). Overall, the range of IgG4 was greater than IgG1, and IgG4 was the dominant subclass in >60% of all subjects.
OVA-specific IgG levels of egg-allergic, egg-resolved or control groups are not distinguishable. Higher peanut-specific IgG levels are associated with clinical allergy, but the range of IgG titres of the allergic and control groups overlapped. Hence, OVA and peanut-specific IgG measurements do not appear to be of diagnostic value. Strong IgG responses to OVA may be a normal physiological response to a protein frequently ingested from infancy, whereas up-regulated IgG responses in peanut allergy may be indicative of a dysregulated immune response to peanut allergens.
食物特异性IgG亚类在食物过敏和耐受中的临床意义尚不清楚。特异性IgG滴度通常以非标准化单位报告,这使得不同研究或过敏原之间无法进行比较。
以绝对单位量化花生或鸡蛋过敏(活动期或已缓解)儿童及非过敏对照者中卵清蛋白(OVA)和花生特异性IgG水平。方法招募1至15岁儿童。通过可靠病史及95%特异性IgE预测水平诊断花生过敏;通过口服激发试验确认鸡蛋过敏或缓解情况。采用酶联免疫吸附测定法(ELISA)定量检测血清中OVA和花生提取物的IgG、IgG1及IgG4水平(微克/毫升)。
所有受试者均检测到OVA和花生特异性IgG。在非过敏对照者(n = 18)中,OVA特异性IgG水平显著高于花生特异性IgG(IgG中位数,微克/毫升:15.9对2.2,IgG1:1.3对0.6,IgG4:7.9对0.7;P < 0.01)。鸡蛋过敏者(n = 40)、鸡蛋过敏已缓解者(n = 22)和对照者(n = 18)之间,OVA特异性IgG、IgG1和IgG4无差异。相比之下,花生过敏者(n = 59)的花生特异性IgG(IgG中位数,微克/毫升:17.0,IgG1:3.3,IgG4:5.2)显著高于对照者及非花生致敏但鸡蛋过敏者(n = 26)。总体而言,IgG4的范围大于IgG1,且在所有受试者中超过60%的人IgG4是主要亚类。
鸡蛋过敏、鸡蛋过敏已缓解或对照组的OVA特异性IgG水平无明显差异。较高的花生特异性IgG水平与临床过敏相关,但过敏组和对照组的IgG滴度范围有重叠。因此,OVA和花生特异性IgG检测似乎没有诊断价值。对OVA的强烈IgG反应可能是对婴儿期经常摄入的一种蛋白质的正常生理反应,而花生过敏中上调的IgG反应可能表明对花生过敏原的免疫反应失调。